Evotec
a portfolio of off the shelf based cell therapy programs | Evotec
Company
Deck Type
Sector
Industry
Deck date
March 2024
Slide
22 of 49
Related slides by other companies
Genprex
Investor Presentation
November 2024
program highlights | Genprex
Boundless Bio
IPO
March 2024
are a primary driver of amplified cancers and enable resistance to targeted therapies | Boundless Bio
Nuvalent
IPO
July 2021
targeted therapies for patients with cancer | Nuvalent
BioNTech
Investor Day
June 2022
platform strategy technology agnostic innovation engine | BioNTech
Other recent decks by Evotec
See all presentations (5 decks)
Investor Presentation
July 2022
ESG
February 2022
Results
August 2021
Investor Day
November 2020
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights